diacrylylpiperazine,
6342-17-2,
1,4-DIACRYLOYLPIPERAZINE,
Diacrylylpiperazine,
1,4-Bis(acryloyl)piperazine,
1,1'-(piperazine-1,4-diyl)bis(prop-2-en-1-one),
1,4-Diacrylylpiperazine,
Piperazine, 1,4-bis(1-oxo-2-propenyl)-,
MFCD00077661,
61133-53-7,
1-[4-(prop-2-enoyl)piperazin-1-yl]prop-2-en-1-one,
1,1'-piperazine-1,4-diylbisprop-2-en-1-one,
ACMC-20ap2o,
AC1Q5BIN,
AC1L4W8E,
BICL800,
KSC352O3L,
SCHEMBL167151,
IFLab1_003395,
CTK2F2735,
DTXSID10212834,
CHEBI:125545,
ZX-AFC003022,
HMS1421K07,
KS-000010ZH,
NSC49404,
ZINC1681330,
ZX-AT021975,
NSC-49404,
NSC133364,
AKOS001021240,
MCULE-4269527710,
NSC-133364,
OR18404,
AS-17350,
CJ-06307,
SC-12593,
U668,
DB-073323,
LS-123956,
RT-004016,
C2683,
FT-0606831,
C-1113,
342D172,
1-(4-prop-2-enoylpiperazin-1-yl)prop-2-en-1-one,
I13-0316,
BRD-K36651625-001-01-6,
F0701-0030,
Piperazine diacrylamide, For acrylamide gel electrophoresis,
1,4-Bis(acryloyl)piperazine, BioXtra, suitable for electrophoresis, >=99.0% (TLC),
1,4-(Diacryloyl)piperazine,
C10H14N2O2,
KST-1B8066,
AR-1B4895,
CID193422,
ACN-051317,
Piperazine,1,4-bis(1-oxo-2-propenyl)-,
1,4-Diacryloylpiperazine, 97% - 5G 5g,
2-Propenoic acid, compd. with piperazine (2:1),
72250-39-6,